Global ANCA Vasculitis Drug Market: Restraint
The major factors that hinder growth of the global ANCA vasculitis drug market include side effects associated with glucocorticoid use such as glucocorticoid toxicity. Higher doses of steroids in ANCA-associated vasculitis (AAV) lead to worse glucocorticoid-related toxicity. Although glucocorticoids remain the main adjunctive immunosuppression of AAV treatment, the narrow therapeutic window supports the need for glucocorticoids-sparing treatments, thus acting as a restraint for the market growth.
Anca Vasculitis Drug Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients